Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.

PLANTATION, FL, and GAITHERSBURG, MD, USA I January 28, 2025 I miRecule, a biotechnology company pioneering RNA therapies, and GBI Biomanufacturing, a leading contract development and manufacturing ...

miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...

Vantaca, the leading community association management software provider, is thrilled to announce the addition of four distinguished executives to its team: Tom Arnett as Chief Strategy Officer, John ...

The Vision Media team is honored to announce a new relationship with Banner Health, one of the largest non-profit hospital systems in the nation and the largest private employer in ...

(MENAFN- PR Newswire) Under the agreement, GBI will leverage its expertise and state-of-the-art facilities to support miRecule in the development and clinical production of its ARC therapies.